Opioid and cannabinoid receptors: friends with benefits or just close friends?
- 1 June 2006
- journal article
- editorial
- Published by Wiley in British Journal of Pharmacology
- Vol. 148 (4) , 385-386
- https://doi.org/10.1038/sj.bjp.0706756
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesisBritish Journal of Pharmacology, 2006
- Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET)Nature Methods, 2006
- Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand seriesProceedings of the National Academy of Sciences, 2005
- Interaction of Bivalent Ligand KDN21 with Heterodimeric δ-κ Opioid Receptors in Human Embryonic Kidney 293 CellsMolecular Pharmacology, 2005
- Methods to monitor the quaternary structure of G protein‐coupled receptorsThe FEBS Journal, 2005
- Selectivity in the oligomerisation of G protein-coupled receptorsSeminars in Cell & Developmental Biology, 2004
- Functional Interactions between μ Opioid and α2A-Adrenergic ReceptorsMolecular Pharmacology, 2003
- G-protein-coupled receptor dimerization: modulation of receptor functionPharmacology & Therapeutics, 2001
- Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activationProceedings of the National Academy of Sciences, 2000